Inpatient management of uncomplicated skin and soft tissue infections in 34 Veterans Affairs medical centers: A medication use evaluation

Journal Article (Journal Article)

Background. Skin and soft tissue infections (SSTIs) are a key antimicrobial stewardship target because they are a common infection in hospitalized patients, and non-guideline-concordant antibiotic use is frequent. To inform antimicrobial stewardship interventions, we evaluated the proportion of veterans hospitalized with SSTIs who received guideline-concordant empiric antibiotics or an appropriate total duration of antibiotics. Methods. A retrospective medication use evaluation was performed in 34 Veterans Affairs Medical Centers between 2016 and 2017. Hospitalized patients who received antibiotics for uncomplicated SSTI were included. Exclusion criteria were complicated SSTI, severe immunosuppression, and antibiotics for any non-SSTI indication. Data were collected by manual chart review. The primary outcome was the proportion of patients receiving both guideline-concordant empiric antibiotics and appropriate treatment duration, defined as 5-10 days of antibiotics. Data were analyzed and reported using descriptive statistics. Results. Of the 3890 patients manually evaluated for inclusion, 1828 patients met inclusion criteria. There were 1299 nonpurulent (71%) and 529 purulent SSTIs (29%). Overall, 250 patients (14%) received guideline-concordant empiric therapy and an appropriate duration. The most common reason for non-guideline-concordance was receipt of antibiotics targeting methicillin-resistant Staphylococcus aureus (MRSA) in 906 patients (70%) with a nonpurulent SSTI. Additionally, 819 patients (45%) received broad-spectrum Gram-negative coverage, and 860 patients (48%) received an antibiotic duration >10 days. Conclusions. We identified 3 common opportunities to improve antibiotic use for patients hospitalized with uncomplicated SSTIs: use of anti-MRSA antibiotics in patients with nonpurulent SSTIs, use of broad-spectrum Gram-negative antibiotics, and prolonged durations of therapy.

Full Text

Duke Authors

Cited Authors

  • Sutton, JD; Carico, R; Burk, M; Jones, MM; Wei, XM; Neuhauser, MM; Goetz, MB; Echevarria, KL; Spivak, ES; Cunningham, FE; Goolsby, T; Witt, L; Hong, J; Landayan, P; Shatz, K; Pontefract, B; Murdock, K; Gallegos-Salazar, J; Strymish, J; Chang, M; Poon, H; Vest, K; Tinsley, N; Bockenstedt, G; Patel, D; Message, J; Ang, G; Banerjee, A; Fry, S; Rose, M; Hiett, J; Tate, V; Fisher, A; Kotansky, B; Vu, V; Dhar, S; Kuhn, R; Willis, S; Britt, R; Townsend, M; Hines, E; Little, E; Williams, L; Ficek, E; Tell, R; Liu, X; Pasciak, J; Iliuta, R; Bennett, J; Germinario, V; Jacobs, E; Spivey, J; Vannoy, M; Foral, P; Feller, C; Nguyen, H; Lu, S; Burns, T; Khan, P; Kouma, M; Buehrle, D; Ruzzi, N; MacKay, K; Tran, L; Emberger, J; Sann, K; Tassone, D; Spivak, E; Chow, S; Ma, A; Gonzalez-Gonzalez, E; Cintron, H; Aylward, A; Daniel, KT; Welu, J; Pickard, C; Sanchez, C; Shafiq, A; Skouby, D; O'Donnell, J; Surdy, M

Published Date

  • January 1, 2020

Published In

Volume / Issue

  • 7 / 1

Electronic International Standard Serial Number (EISSN)

  • 2328-8957

Digital Object Identifier (DOI)

  • 10.1093/ofid/ofz554

Citation Source

  • Scopus